IBDEI0P6 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11233,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,11233,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,11233,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,11234,0)
 ;;=B00.59^^77^727^32
 ;;^UTILITY(U,$J,358.3,11234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11234,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,11234,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,11234,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,11235,0)
 ;;=Z01.00^^77^727^30
 ;;^UTILITY(U,$J,358.3,11235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11235,1,3,0)
 ;;=3^Eye/Vision Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,11235,1,4,0)
 ;;=4^Z01.00
 ;;^UTILITY(U,$J,358.3,11235,2)
 ;;=^5062612
 ;;^UTILITY(U,$J,358.3,11236,0)
 ;;=Z01.01^^77^727^29
 ;;^UTILITY(U,$J,358.3,11236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11236,1,3,0)
 ;;=3^Eye/Vision Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,11236,1,4,0)
 ;;=4^Z01.01
 ;;^UTILITY(U,$J,358.3,11236,2)
 ;;=^5062613
 ;;^UTILITY(U,$J,358.3,11237,0)
 ;;=H52.213^^77^727^2
 ;;^UTILITY(U,$J,358.3,11237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11237,1,3,0)
 ;;=3^Astigmatism,Irregular,Bilateral
 ;;^UTILITY(U,$J,358.3,11237,1,4,0)
 ;;=4^H52.213
 ;;^UTILITY(U,$J,358.3,11237,2)
 ;;=^5006272
 ;;^UTILITY(U,$J,358.3,11238,0)
 ;;=H52.223^^77^727^3
 ;;^UTILITY(U,$J,358.3,11238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11238,1,3,0)
 ;;=3^Astigmatism,Regular,Bilateral
 ;;^UTILITY(U,$J,358.3,11238,1,4,0)
 ;;=4^H52.223
 ;;^UTILITY(U,$J,358.3,11238,2)
 ;;=^5006276
 ;;^UTILITY(U,$J,358.3,11239,0)
 ;;=H40.1113^^77^727^49
 ;;^UTILITY(U,$J,358.3,11239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11239,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,11239,1,4,0)
 ;;=4^H40.1113
 ;;^UTILITY(U,$J,358.3,11239,2)
 ;;=^5138539
 ;;^UTILITY(U,$J,358.3,11240,0)
 ;;=H40.1123^^77^727^50
 ;;^UTILITY(U,$J,358.3,11240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11240,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage,Left Eye
 ;;^UTILITY(U,$J,358.3,11240,1,4,0)
 ;;=4^H40.1123
 ;;^UTILITY(U,$J,358.3,11240,2)
 ;;=^5138544
 ;;^UTILITY(U,$J,358.3,11241,0)
 ;;=H35.3110^^77^727^39
 ;;^UTILITY(U,$J,358.3,11241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11241,1,3,0)
 ;;=3^Nonexudative ARMD,Right Eye
 ;;^UTILITY(U,$J,358.3,11241,1,4,0)
 ;;=4^H35.3110
 ;;^UTILITY(U,$J,358.3,11241,2)
 ;;=^5138500
 ;;^UTILITY(U,$J,358.3,11242,0)
 ;;=H35.3120^^77^727^38
 ;;^UTILITY(U,$J,358.3,11242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11242,1,3,0)
 ;;=3^Nonexudative ARMD,Left Eye
 ;;^UTILITY(U,$J,358.3,11242,1,4,0)
 ;;=4^H35.3120
 ;;^UTILITY(U,$J,358.3,11242,2)
 ;;=^5138505
 ;;^UTILITY(U,$J,358.3,11243,0)
 ;;=H35.3210^^77^727^26
 ;;^UTILITY(U,$J,358.3,11243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11243,1,3,0)
 ;;=3^Exudative ARMD,Right Eye
 ;;^UTILITY(U,$J,358.3,11243,1,4,0)
 ;;=4^H35.3210
 ;;^UTILITY(U,$J,358.3,11243,2)
 ;;=^5138520
 ;;^UTILITY(U,$J,358.3,11244,0)
 ;;=H35.3220^^77^727^25
 ;;^UTILITY(U,$J,358.3,11244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11244,1,3,0)
 ;;=3^Exudative ARMD,Left Eye
 ;;^UTILITY(U,$J,358.3,11244,1,4,0)
 ;;=4^H35.3220
 ;;^UTILITY(U,$J,358.3,11244,2)
 ;;=^5138524
 ;;^UTILITY(U,$J,358.3,11245,0)
 ;;=E11.3291^^77^727^15
 ;;^UTILITY(U,$J,358.3,11245,1,0)
 ;;=^358.31IA^4^2
